Nautilus Biotechnology
Nautilus is a company dedicated to revolutionizing biomedicine by unlocking the complexity of the proteome. They develop advanced single-molecule proteomics platforms that analyze billions of proteins or proteoforms at the single-molecule level, enabling broadscale and targeted proteomics studies. Their mission is to positively impact health worldwide through deep scientific innovation and transformative technology.
Industries
Nr. of Employees
medium (51-250)
Nautilus Biotechnology
2701 Eastlake Avenue East Seattle, WA 98102
Patents
Products
Single-molecule proteome analysis platform
Integrated platform that performs single-molecule interrogation of intact proteins on hyper-dense nanoarrays using multi-affinity probes, computational decoding, and cloud-based analysis to provide protein and proteoform identities and counts.
Single-molecule proteome analysis platform
Integrated platform that performs single-molecule interrogation of intact proteins on hyper-dense nanoarrays using multi-affinity probes, computational decoding, and cloud-based analysis to provide protein and proteoform identities and counts.
Services
Engagements to collaborate on proteomics experiments and data generation using the single-molecule proteome analysis platform; includes integrated sample-to-data workflows and joint data interpretation.
Engagements to collaborate on proteomics experiments and data generation using the single-molecule proteome analysis platform; includes integrated sample-to-data workflows and joint data interpretation.
Expertise Areas
- Broadscale (discovery) proteomics
- Proteoform-focused assays and analysis
- Single-molecule detection and quantification
- Affinity-reagent and probe development
Key Technologies
- Single-molecule proteomics
- Multi-affinity probe assays
- Nanofabricated hyper-dense protein arrays
- Fluorescence microscopy-based detection
News & Updates
Parag Mallick received the 2024 Gilbert S. Omenn Computational Proteomics Award at US HUPO 2024.
Exploring how proteomics advances cancer diagnostics and treatments.
Parag Mallick was awarded the 2024 Omenn Award for contributions to computational proteomics.
Parag Mallick received the 2024 Gilbert S. Omenn Computational Proteomics Award at US HUPO 2024.
Exploring how proteomics advances cancer diagnostics and treatments.
Parag Mallick was awarded the 2024 Omenn Award for contributions to computational proteomics.